Company: HCTI
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026218
Chunk: 213

Company: Healthcare Triangle, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1A
Chunk 213
---

    Interest 
     121  
     968 
  
    Income tax 
    $12  
    $35 

    Non-cash flow information 

    Contingent consideration settled with common stock 
     -  
     125 
  
    Relative fair value of warrants issued with convertible debt 
     -  
     356 
  
    Conversion of debt for common stock 
     1,181  
     - 
  
    Issuance of Series B preferred stock in connection with acquisition of customer contracts from a common control entity 
    $7,435  
    $- 

The accompanying notes are an integral part of
these consolidated financial statements.

F-6

HEALTHCARE TRIANGLE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(in thousands except share and per share data)

1) Organization and Description of Business

Healthcare Triangle Inc. (“the Company”)
was incorporated under the laws of the State of Nevada on October 29, 2019, and then converted into a Delaware corporation on April 24,
2020, to provide IT and data services to the Healthcare and Life Sciences (‘HCLS”) industry. On January 1, 2020, the Company
acquired the Life Sciences Business of SecureKloud Technologies Inc. and on May 8, 2020, the Company acquired Cornerstone Advisors Group
LLC (Healthcare Business) from SecureKloud.

Healthcare Triangle, Inc. (HTI) reinforces healthcare
progress through breakthrough technology and extensive industry know-how. HTI support healthcare providers and payors, hospitals and Pharma/Life
Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business
agility and accelerate responding to immediate business needs and competitive threats. The highly regulated HCLS industry turn to HTI
for expertise in digital transformation on the cloud, security and compliance, develops, data lifecycle management, healthcare interoperability,
clinical and business performance optimization.

HTI will concentrate on accelerating value to three healthcare sectors:

    1.
    Pharmaceutical companies, which require improved efficiencies in the clinical trial process. HTI modernizes their IT infrastructure to advance the clinical trial process to drug discovery and delivery.

    2.
    Hospitals and health systems, which face interoperability challenges as mergers, acquisitions and partnerships drive increasing need for integrated healthcare infrastructures. HTI’s health IT expertise optimizes providers